Clinical Trial Update: A Safety Study of Hylan GF-20 to Treat Shoulder Osteoarthritis [Phase 4]

View source ↗

Summary

A Phase 4 safety study evaluating Hylan GF-20 for shoulder osteoarthritis is being updated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shoulder Osteoarthritis

Drugs mentioned

• Hylan GF-20

Snippet

Sponsor: Northwestern Ophthalmic Institute S.C. | Conditions: Painful Shoulder Osteoarthritis | Phase 4 | Status: UNKNOWN